The Shotlee Journal
Browse Shotlee articles about Mounjaro.
Showing 9 / 801 Mounjaro articles
Peptides are short amino acid chains hailed by influencers for wellness benefits like injury repair and weight loss, but many lack human evidence. From approved drugs like semaglutide in Wegovy to unregulated options like the 'Wolverine stack' of BPC-157 and TB-500, we examine the science, legality, and risks in the UK.
The NHS has expanded free Wegovy access to 1.2 million more people, but a doctor is urging caution over a 'miserable' side effect: constipation. Dr. Suraj Kukadia explains how GLP-1 medications like Wegovy slow digestion, leading to this common issue. Discover the mechanism and tips for those considering these weight loss jabs.
The rise of Ozempic and similar GLP-1 medications is dramatically altering dining out habits across America, with users ordering less food and leaving meals uneaten. Restaurants face revenue pressures as customers skip courses and reduce alcohol intake. Forward-thinking spots are introducing smaller portions and tapas-style menus to adapt.
In India, 'Mounjaro brides' are using weight-loss injections as part of pre-wedding rituals, driven by intense societal expectations. Clinics like Klarity Skin Clinic offer specialized packages, while doctors report a surge in queries from brides and grooms. This trend highlights both the drugs' popularity and the need for medical supervision.
A 27-year-old man from Wigan is being hunted by police after failing to appear in court on charges of stealing over £12,000 worth of Mounjaro weight loss injections from his workplace. The theft highlights the skyrocketing demand for this GLP-1 medication used for type 2 diabetes and appetite control. Understand the case details and what makes Mounjaro so sought after.
Vice President JD Vance appeared noticeably slimmer in a recent interview with Benny Johnson, igniting Ozempic rumors across X. Netizens speculate on the popular weight-loss drug amid past denials and critic backlash. While no confirmation exists, the buzz highlights Ozempic's role in metabolic health conversations.
Novo Nordisk's latest comparison study claims its Wegovy pill delivers superior weight loss compared to Eli Lilly's newly approved Foundayo tablet. The ORION analysis shows a 3.2 percentage point edge for oral semaglutide, plus lower discontinuation rates due to side effects. As oral GLP-1s compete, discover the key findings and implications for patients.
Eli Lilly's Foundayo, a new GLP-1 weight loss pill, just received FDA approval with key advantages: take it anytime without food or water restrictions. Backed by trials showing 12% body weight loss over 72 weeks, it aims to make obesity treatment more accessible. Compare pricing, side effects, and how it stacks up against Wegovy and injectables.
Eli Lilly is leveraging artificial intelligence to find its next big breakthrough after the GLP-1 boom transformed diabetes and obesity treatment. With rivals like Novo Nordisk in hot pursuit, Lilly's AI investments promise faster drug discovery and smarter clinical trials. This strategic shift could diversify revenue and bring new options to patients sooner.
